Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10058996HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059015HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059003HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060320HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060335HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060327HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10061253HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059002HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060328HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060319HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB00276
Drug NameAmsacrine
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs10803926
CitationsFinlay GJ, Baguley BC: Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Cancer Chemother Pharmacol. 2000;45(5):417-22.
GroupsApproved; Investigational
Direct ClassificationAcridines
SMILESCOC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Pathways
PharmGKBPA10309
ChEMBLCHEMBL43